Literature DB >> 28444299

Environmental factors associated with disease flare in juvenile and adult dermatomyositis.

Gulnara Mamyrova1, Lisa G Rider2, Alison Ehrlich3, Olcay Jones4, Lauren M Pachman5, Robert Nickeson6, Lisa G Criscone-Schreiber7, Lawrence K Jung8, Frederick W Miller2, James D Katz1,9.   

Abstract

Objective: The aim was to assess environmental factors associated with disease flare in juvenile and adult dermatomyositis (DM).
Methods: An online survey of DM patients from the USA and Canada examined smoking, sun exposure, infections, medications, vaccines, stressful life events and physical activity during the 6 months before flares, or in the past 6 months in patients without flares. Differences were evaluated by χ 2 and Fisher's exact tests, and significant univariable results were examined in multivariable logistic regression. Residential locations before flare were correlated with the National Weather Service UV index.
Results: Of 210 participants (164 juvenile and 46 adult DM), 134 (63.8%) experienced a disease flare within 2 years of the survey. Subjects more often reported disease flare after sun exposure [odds ratio (OR) = 2.0, P = 0.03], although use of photoprotective measures did not differ between those with and without flare. Urinary tract infections (OR = 16.4, P = 0.005) and gastroenteritis (OR = 3.2, P = 0.04) were more frequent in the preceding 6 months in those who flared. Subjects who flared recently used NSAIDS (OR = 3.0, P = 0.0003), blood pressure medicines (OR = 3.5, P = 0.049) or medication for depression or mood changes (OR = 12.9, P = 0.015). Moving to a new house (OR = 10.3, P = 0.053) was more common in those who flared. Only sun exposure (OR = 2.2) and NSAIDs (OR = 1.9) were significant factors in multivariable analysis.
Conclusion: Certain classes of environmental agents that have been associated with the initiation of DM, including sun exposure and medications, may also play a role in disease flares. Published by Oxford University Press on behalf of the British Society for Rheumatology 2017. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  dermatomyositis; disease flare; environmental factors; juvenile dermatomyositis

Mesh:

Substances:

Year:  2017        PMID: 28444299      PMCID: PMC5850835          DOI: 10.1093/rheumatology/kex162

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  16 in total

1.  Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases.

Authors:  Ju Ann Tan; Peter J Roberts-Thomson; Peter Blumbergs; Paul Hakendorf; Sally R Cox; Vidya Limaye
Journal:  Int J Rheum Dis       Date:  2011-10-13       Impact factor: 2.454

2.  History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry.

Authors:  Lauren M Pachman; Rebecca Lipton; Rosalind Ramsey-Goldman; Eli Shamiyeh; Kathy Abbott; Eduardo P Mendez; Alan Dyer; Deborah Mc Curdy; Larry Vogler; Ann Reed; Gail Cawkwell; Lawrence Zemel; Christy Sandborg; Rafael Rivas-Chacon; Christine Hom; Norman Ilowite; Abraham Gedalia; Jonathan Gitlin; Michael Borzy
Journal:  Arthritis Rheum       Date:  2005-04-15

3.  Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis.

Authors:  Mona Shah; Ira N Targoff; Madeline M Rice; Frederick W Miller; Lisa G Rider
Journal:  Arthritis Rheum       Date:  2013-07

Review 4.  State of the art: what we know about infectious agents and myositis.

Authors:  Lu Gan; Frederick W Miller
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

5.  Risk factors for juvenile dermatomyositis: exposure to tobacco and air pollutants during pregnancy.

Authors:  Maria Angélica M Orione; Clovis A Silva; Adriana M E Sallum; Lúcia M A Campos; Clarissa H Omori; Alfésio L F Braga; Sylvia C L Farhat
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-10       Impact factor: 4.794

6.  Exposure to Air Pollutants and Disease Activity in Juvenile-Onset Systemic Lupus Erythematosus Patients.

Authors:  Elisabeth C Fernandes; Clovis A Silva; Alfésio L F Braga; Adriana M E Sallum; Lúcia M A Campos; Sylvia C L Farhat
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-11       Impact factor: 4.794

7.  Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study.

Authors:  Rachana Hasija; Angela Pistorio; Angelo Ravelli; Erkan Demirkaya; Raju Khubchandani; Dinara Guseinova; Clara Malattia; Helena Canhao; Liora Harel; Dirk Foell; Carine Wouters; Carmen De Cunto; Christian Huemer; Yukiko Kimura; Harald Mangge; Carlo Minetti; Ellen Berit Nordal; Pierre Philippet; Rosaria Garozzo; Alberto Martini; Nicolino Ruperto
Journal:  Arthritis Rheum       Date:  2011-10

Review 8.  Mechanisms of disease: Environmental factors in the pathogenesis of rheumatic disease.

Authors:  Mark Gourley; Frederick W Miller
Journal:  Nat Clin Pract Rheumatol       Date:  2007-03

9.  Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies.

Authors:  Lisa G Rider; Lan Wu; Gulnara Mamyrova; Ira N Targoff; Frederick W Miller
Journal:  Rheumatology (Oxford)       Date:  2010-08-27       Impact factor: 7.580

10.  Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders.

Authors:  Frederick W Miller; Robert G Cooper; Jiří Vencovský; Lisa G Rider; Katalin Danko; Lucy R Wedderburn; Ingrid E Lundberg; Lauren M Pachman; Ann M Reed; Steven R Ytterberg; Leonid Padyukov; Albert Selva-O'Callaghan; Timothy R D J Radstake; David A Isenberg; Hector Chinoy; William E R Ollier; Terrance P O'Hanlon; Bo Peng; Annette Lee; Janine A Lamb; Wei Chen; Christopher I Amos; Peter K Gregersen
Journal:  Arthritis Rheum       Date:  2013-12
View more
  16 in total

Review 1.  Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity.

Authors:  Lauren M Pachman; Amer M Khojah
Journal:  J Pediatr       Date:  2018-04       Impact factor: 4.406

Review 2.  Risk factors and disease mechanisms in myositis.

Authors:  Frederick W Miller; Janine A Lamb; Jens Schmidt; Kanneboyina Nagaraju
Journal:  Nat Rev Rheumatol       Date:  2018-04-20       Impact factor: 20.543

Review 3.  [Juvenile dermatomyositis-what's new?]

Authors:  C Hinze
Journal:  Z Rheumatol       Date:  2019-09       Impact factor: 1.372

Review 4.  Advances Toward Precision Medicine in Juvenile Dermatomyositis.

Authors:  Jessica Neely; Susan Kim
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

Review 5.  Idiopathic inflammatory myopathies.

Authors:  Ingrid E Lundberg; Manabu Fujimoto; Jiri Vencovsky; Rohit Aggarwal; Marie Holmqvist; Lisa Christopher-Stine; Andrew L Mammen; Frederick W Miller
Journal:  Nat Rev Dis Primers       Date:  2021-12-02       Impact factor: 52.329

Review 6.  Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target.

Authors:  Ruixuan You; Xinglan He; Zhuotong Zeng; Yi Zhan; Yangfan Xiao; Rong Xiao
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

7.  Statin use in patients with non-HMGCR idiopathic inflammatory myopathies: A retrospective study.

Authors:  Sangmee Sharon Bae; Buzand Oganesian; Ilana Golub; Christina Charles-Schoeman
Journal:  Clin Cardiol       Date:  2020-05-20       Impact factor: 2.882

Review 8.  Recent developments in classification criteria and diagnosis guidelines for idiopathic inflammatory myopathies.

Authors:  Alexander Oldroyd; Hector Chinoy
Journal:  Curr Opin Rheumatol       Date:  2018-11       Impact factor: 5.006

Review 9.  Current Classification and Management of Inflammatory Myopathies.

Authors:  Jens Schmidt
Journal:  J Neuromuscul Dis       Date:  2018

10.  Drug-induced dermatomyositis after lacosamide: A case report.

Authors:  Rebecca G Gaffney; Meera Tarazi; Victoria P Werth
Journal:  JAAD Case Rep       Date:  2018-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.